Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 7
«Preious | of 2 |
1

非小细胞肺癌中EML4-ALK融合基因的存在状态及临床意义

Drug Evaluation, , Issue 30,2012, Pages 8-14, doi:10.3969/j.issn.1672-2809.2012.30.004

2

埃克替尼治疗30例晚期非小细胞肺癌的近期疗效及安全性分析

Drug Evaluation, , Issue 30,2012, Pages 24-27, doi:10.3969/j.issn.1672-2809.2012.30.009

3

盐酸埃克替尼治疗肺腺癌脑转移1例并文献复习

Drug Evaluation, , Issue 30,2012, Pages 47-48, doi:10.3969/j.issn.1672-2809.2012.30.014

4

鞍区肿瘤术后并发尿崩症的相关因素与护理

Drug Evaluation, , Issue 30,2012, Pages 31-35, doi:10.3969/j.issn.1672-2809.2012.30.011

Items 1-5 of 7
«Preious | of 2 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn